Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Veracyte Inc (VCYT)
Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,634,715
  • Shares Outstanding, K 72,751
  • Annual Sales, $ 296,540 K
  • Annual Income, $ -36,560 K
  • 60-Month Beta 1.32
  • Price/Sales 5.54
  • Price/Cash Flow N/A
  • Price/Book 1.56
Trade VCYT with:

Options Overview Details

View History
  • Implied Volatility 78.88% ( -5.20%)
  • Historical Volatility 32.86%
  • IV Percentile 38%
  • IV Rank 61.11%
  • IV High 124.11% on 10/24/22
  • IV Low 7.80% on 10/19/22
  • Put/Call Vol Ratio 0.83
  • Today's Volume 77
  • Volume Avg (30-Day) 177
  • Put/Call OI Ratio 0.44
  • Today's Open Interest 2,501
  • Open Int (30-Day) 2,410

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/23
See More
  • Average Estimate -0.16
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.17
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -33.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.20 +1.19%
on 09/22/23
27.27 -17.60%
on 09/01/23
-3.52 (-13.54%)
since 08/22/23
3-Month
22.20 +1.19%
on 09/22/23
30.52 -26.38%
on 07/18/23
-4.03 (-15.21%)
since 06/22/23
52-Week
14.92 +50.60%
on 10/21/22
32.40 -30.65%
on 12/13/22
+5.76 (+34.47%)
since 09/22/22

Most Recent Stories

More News
Is This Underfollowed Genetic Diagnostics Stock a Buy for Growth Investors?

The genetic test maker is rapidly increasing test volumes.

AZN : 67.83 (+1.21%)
COMP : 3.07 (+5.14%)
VCYT : 22.47 (-0.58%)
Veracyte: Q2 Earnings Snapshot

Veracyte: Q2 Earnings Snapshot

VCYT : 22.47 (-0.58%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

/PRNewswire/ -- USA News Group - With this year's Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there's...

ONC.TO : 2.91 (-1.36%)
ONCY : 2.16 (-1.37%)
JAZZ : 131.75 (-0.74%)
GERN : 2.15 (-0.92%)
INAB : 1.2300 (+6.03%)
VCYT : 22.47 (-0.58%)
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END

ONCY : 2.16 (-1.37%)
ONC.TO : 2.91 (-1.36%)
JAZZ : 131.75 (-0.74%)
GERN : 2.15 (-0.92%)
INAB : 1.2300 (+6.03%)
VCYT : 22.47 (-0.58%)
Significant Oncology Results Set to be Delivered as Oral Presentations at ASCO 2023

USA News Group – With this year’s Annual Meeting of the American Society of Clinical Oncology (ASCO 2023) less than 30 days away, there’s plenty of anticipation for updates on some of the biggest...

ONCY : 2.16 (-1.37%)
ONC.TO : 2.91 (-1.36%)
JAZZ : 131.75 (-0.74%)
GERN : 2.15 (-0.92%)
INAB : 1.2300 (+6.03%)
VCYT : 22.47 (-0.58%)
Here's Why This Little-Known Growth Stock Is a Buy

Analysts think this genomic test maker could have major upside in the next year.

VCYT : 22.47 (-0.58%)
A New Groundbreaking Tool to Detect Colon Cancer Earlier

A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This discovery...

MYNZ : 3.13 (-0.63%)
EXAS : 66.85 (-3.85%)
GH : 25.93 (-0.69%)
VCYT : 22.47 (-0.58%)
HOLX : 70.21 (+0.20%)
Veracyte (VCYT) Reports Q1 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 21.43% and 6.94%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VCYT : 22.47 (-0.58%)
MASS : 6.04 (+0.67%)
Veracyte: Q1 Earnings Snapshot

Veracyte: Q1 Earnings Snapshot

VCYT : 22.47 (-0.58%)
Veracyte Announces First Quarter 2023 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2023.

VCYT : 22.47 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

3rd Resistance Point 23.67
2nd Resistance Point 23.33
1st Resistance Point 22.90
Last Price 22.47
1st Support Level 22.12
2nd Support Level 21.78
3rd Support Level 21.35

See More

52-Week High 32.40
Fibonacci 61.8% 25.72
Fibonacci 50% 23.66
Last Price 22.47
Fibonacci 38.2% 21.60
52-Week Low 14.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar